T. Rowe Price Associates’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
32,108
+5,422
| +20% | +$66.9K | ﹤0.01% | 2410 |
|
|
2025
Q1 | $165K | Buy |
26,686
+3,241
| +14% | +$20K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $190K | Buy |
23,445
+5,030
| +27% | +$40.8K | ﹤0.01% | 2696 |
|
|
2024
Q3 | $149K | Buy |
18,415
+2,334
| +15% | +$18.9K | ﹤0.01% | 2748 |
|
|
2024
Q2 | $70K | Buy |
16,081
+1,446
| +10% | +$6.29K | ﹤0.01% | 2804 |
|
|
2024
Q1 | $63K | Buy |
14,635
+2,562
| +21% | +$11K | ﹤0.01% | 2842 |
|
|
2023
Q4 | $46K | Hold |
12,073
| – | – | ﹤0.01% | 2814 |
|
|
2023
Q3 | $45K | Buy |
+12,073
| New | +$45K | ﹤0.01% | 2784 |
|
|
2021
Q4 | – | Sell |
-17,527
| Closed | -$82K | – | 2990 |
|
|
2021
Q3 | $82K | Hold |
17,527
| – | – | ﹤0.01% | 2864 |
|
|
2021
Q2 | $120K | Buy |
17,527
+912
| +5% | +$6.24K | ﹤0.01% | 2813 |
|
|
2021
Q1 | $166K | Buy |
+16,615
| New | +$166K | ﹤0.01% | 2722 |
|